Nov 6-9, 2024
DGN Congress 2024: Sponsorship award for Dr. Patricia Krause
TRR 295 ReTune at the DGN Congress 2024 in Berlin
Neurology and immunology – joint perspectives!
The DGN Congress is the largest specialist congress for neurology in Europe. More than 7,000 neurologists from all over Germany and neighboring German-speaking countries take part in this hybrid congress every year.
Three colleagues who focus their research and work on neurology attended this year’s DGN Congress: Prof. Andrea Kühn, Dr. Patricia Krause and Prof. Jens Volkmann.
On the first day of the DGN Congress 2024, a lecture on genetics and biomarkers in Parkinson’s disease was held as part of the Thiemann Symposium. It focused on the increasing importance of genetic diagnostics and possible associated biomarkers. These could enable further personalization of diagnostics and therapy. Clearly defined cohorts could be identified to develop cause-specific treatment approaches. Genetic diagnostics could also allow us to determine specific progression parameters to gain a deeper biological understanding of Parkinson’s disease.
The highlight of the second day was Dr. Patricia Krause’s presentation on the “CARE-PD” project, followed by the awarding of the sponsorship prize to her, Dr. Johanna Reimer and Katharina Bereswill. With the “CARE-PD” study, the researchers aim to investigate the following questions:
- Which factors place a particular burden on family caregivers?
- Is more self-care or more knowledge helpful to them?
- How does reducing the burden on caregivers affect the well-being of patients?
Helping sufferers and their relatives is not their only goal: “Relieving the burden on caregivers is also relevant to health economics,” says Dr. Krause.
In our aging society, the number of Parkinson’s sufferers is constantly increasing, and relatives play a central role in providing care.
The sponsorship award is a start-up financing of 5,000 euros for an intervention study with the aim of reducing the so-called caregiver burden of relatives of Parkinson’s patients at Charité – Universitätsmedizin Berlin. The researchers would like to carry out this study in the neurological day clinic. First, they want to assess the existing burden on caregivers to subsequently reduce it as part of a controlled intervention study. This should also increase the well-being of Parkinson’s patients.
© Picture: Deutsche Hirnstiftung
